1993P A randomized, phase II trial to evaluate the safety and efficacy of eribulin mesylate in combination with atezolizumab compared to atezolizumab alone in subjects with locally advanced or metastatic transitional cell urothelial cancer where cisplatin-based treatment is not an option
| Autor: | D'Souza, A.A., Mar, N., Parikh, R., Parikh, M., Arora, M., Hinton, S., Lyou, Y.M., Ohr, J., Peracha, S., Sadeghi, S., Sulecki, M., Thomas, R.A., Villalona-Calero, M., Lara, P.N., Sharon, E., Krailo, M., Quinn, D.I. |
|---|---|
| Zdroj: | In Annals of Oncology September 2024 35 Supplement 2:S1153-S1153 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|